NRG BN007
A Randomized Phase II/III Open Label Study of Ipilimumab and Nivolumab Versus Temeozolomide in Patients With Newly Diagnosed MGMT (Tumor o-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
More Information
CNS-201
A Multicenter, Open-Label Study with a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients with Recurrent Glioblastoma Multiforme (WHO Grade IV) After Failure of Standard First Line Therapy
More Information
LBSTR
Louisiana Brain and Spine Tumor Registry (LBSTR)
